Definition of Acylsulfonamides. Meaning of Acylsulfonamides. Synonyms of Acylsulfonamides

Here you will find one or more explanations in English for the word Acylsulfonamides. Also in the bottom left of the page several parts of wikipedia pages related to the word Acylsulfonamides and, of course, Acylsulfonamides synonyms and on the right images related to the word Acylsulfonamides.

Definition of Acylsulfonamides

No result for Acylsulfonamides. Showing similar results...

Meaning of Acylsulfonamides from wikipedia

- molecules and marketed drugs, serving as an useful pharmacop****. Acylsulfonamides are of particular interest due to their ability to act as bioisosteres...
- Venetoclax, sold under the brand names Venclexta and Venclyxto, is a medication used to treat adults with chronic lymphocytic leukemia (CLL), small lymphocytic...
- Sulfafurazole (INN, also known as sulfisoxazole) is a sulfonamide antibacterial with a dimethyl-isoxazole substituent. It possesses antibiotic activity...
- Glecaprevir (INN,) is a hepatitis C virus (HCV) nonstructural (NS) protein 3/4A protease inhibitor that was identified jointly by AbbVie and Enanta Pharmaceuticals...
- Navitoclax (previously ABT-263) is an experimental orally active anti-cancer drug, which is a Bcl-2 inhibitor similar in action to obatoclax. Navitoclax...
- Sonrotoclax is an investigational new drug that is being evaluated for the treatment of hematologic malignancies, particularly chronic lymphocytic leukemia...
- Sulprostone is an analogue of prostaglandin E2 (PGE2) that has oxytocic activity in ****ays of rat kidney cells and tissues. There are four known receptors...
- Parecoxib, sold under the brand name Dynastat among others, is a water-soluble and injectable prodrug of valdecoxib. Parecoxib is a COX2 selective inhibitor...
- Lisaftoclax is an investigational new drug being developed by Ascentage Pharma for the treatment of hematological malignancies, particularly chronic lymphocytic...
- Vaniprevir (MK-7009) is a macrocyclic hepatitis C virus (HCV) NS3/4A protease inhibitor, developed by Merck & Co., which is currently in clinical testing...